Amyloid‐Related Imaging Abnormalities in the DIAN‐TU‐001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease
Journal article published in 2022 by
Nelly Joseph‐Mathurin 
,
Jorge J. Llibre‐Guerra,
Yan Li,
Austin A. McCullough,
Carsten Hofmann,
Jakub Wojtowicz,
Ethan Park,
Guoqiao Wang,
Gregory M. Preboske,
Qing Wang,
Brian A. Gordon,
Charles D. Chen,
Shaney Flores,
Neelum T. Aggarwal,
Sarah B. Berman
and other authors.
,
Jorge J. Llibre‐Guerra,
Yan Li,
Austin A. McCullough,
Carsten Hofmann,
Jakub Wojtowicz,
Ethan Park,
Guoqiao Wang,
Gregory M. Preboske,
Qing Wang,
Brian A. Gordon,
Charles D. Chen,
Shaney Flores,
Neelum T. Aggarwal,
Sarah B. Berman
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 